At-home saliva test could help diagnose Prostate cancer sooner

At-home saliva test could help diagnose prostate cancer sooner.
by Tim Gunn | News
1 June 2024

A new saliva test for identifying men at high risk of prostate cancer could help find more cases of the disease earlier, when doctors have a better chance of treating it successfully.

The researchers behind the BARCODE 1 study, which we helped fund, say their test could help “turn the tide” on prostate cancer.
.
.
The new test also falsely identified prostate cancer fewer times than the PSA test does, and picked up a higher proportion of aggressive cancers.

“With this test, it could be possible to turn the tide on prostate cancer,” said Ros Eeles, a professor at the Institute of Cancer Research and a consultant at the Royal Marsden NHS Foundation Trust, which jointly led the research. ”We have shown that a simple, cheap spit test to identify men at higher risk due to their genetic makeup is an effective tool to catch the cancer early.”

Eeles is presenting the results of BARCODE 1 at the annual American Society of Clinical Oncology meeting in Chicago. She ties her work to a long legacy of research into the genetic markers of prostate cancer.

“Building on decades of research into the genetic markers of prostate cancer, our study shows that the theory does work in practice – we can identify men at risk of aggressive cancers who need further tests, and spare the men who are at lower risk from unnecessary treatments.”
.
.
Read the full article: https://news.cancerresearchuk.org/2024/06/01/at-home-saliva-test-spit-test-diagnose-prostate-cancer/
Also another on the BBC: https://www.bbc.com/news/articles/cw44e32veg3o

--------------
Great marketing exposure I wish we had it for our mature Prostate Test..
I don't understand why GTG who have had a GeneType peer reviewed Prostate Cancer salver test for sometime now & it seems cannot market their product properly, meanwhile others have had time to develop theirs and get a spot on the BBC and more.

I just hope a GTG representative is presenting at the same annual American Society of Clinical Oncology meeting in Chicago as Ross Eeles is for all GTG shareholders sake!!

The GTG CEO needs to get a bomb under him, he sits on eggs that never hatch, how much more proof, he really has to go..
He's all talk with no action and NO Shareholder Value creation because of it, just look at the SP.. at Trash levels..

GLAH.
.